AIGEA Medical

AIGEA Medical develops proprietary generative AI algorithms, DeepMammo, to support digital imaging workflows for breast cancer diagnosis. This technology increases radiologist performance by automating repetitive tasks, thereby enhancing diagnostic accuracy and reducing daily workloads. The platform optimizes triage and speeds up cancer diagnosis, leading to shorter screening times.

Traction –/10

Pisa, Italy · HQ

5300+ followers

Artificial Intelligence
Healthcare Technology
Software Only

Updated 4 months ago

Funding

Raised to date

$30KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Carlo Aliprandi

Pisa, Italy

Co-founder & CEO

Profile summary: Extra Red • AI & Data Science Manager - R&D Manager

Federico Picardi

Buti, Italy

Co-founder - Chief Marketing Officier (CMO)

Profile summary: Fondazione Campus Studi del Mediterraneo • Professor

Product

Features

AIGEA Medical develops proprietary generative AI algorithms, DeepMammo, to support digital imaging workflows for breast cancer diagnosis. This technology increases radiologist performance by automating repetitive tasks, thereby enhancing diagnostic accuracy and reducing daily workloads. The platform optimizes triage and speeds up cancer diagnosis, leading to shorter screening times.